ADAR1 (Adenosine Deaminase Acting On RNA 1) (AA 1116-1176) anticorps
Aperçu rapide pour ADAR1 (Adenosine Deaminase Acting On RNA 1) (AA 1116-1176) anticorps (ABIN306686)
Antigène
Reactivité
Hôte
Clonalité
Application
-
-
Épitope
- AA 1116-1176
-
Réactivité croisée
- Rat
-
Attributs du produit
- DRADA, double strandard RNA specific adenosine deaminase 1, ADAR1,Double stranded RNA specific adenosine deaminase 1 (ADAR1 or DRADA) is an enzyme involved in the editing of mammalian messenger RNAs by the site specific conversion of adenosine to inosine. ADAR 1 is thought to play a role in the editing of transcripts encoding non-NMDA glutamate receptor subunits, the 2C subtype of serotonin receptor, as well as hepatitis delta virus antigen.
-
Purification
- Antigen Immunoaffiinity Purification
-
Immunogène
- Sheep were immunized with a GST fusion protein containing amino acid 1116-1176 of the rat DRADA coding sequence. The fusion protein was constructed in the pGEX-KG vector by inserting a fragment corresponding to nucleotides +3346 through +3525 of DRADA at the XbaI and XhoI sites in the vector.
-
Isotype
- IgG
-
-
-
Indications d'application
- Immunoblotting - recommended dilution of 1:1000.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Provided as solution in phosphate buffered saline with 0.08 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
-
-
- ADAR1 (Adenosine Deaminase Acting On RNA 1)
Antigène
-